TCM
EBS icon

Teza Capital Management’s Emergent Biosolutions EBS Stock Holding History

Teza Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-18,542
Closed -$936K – 423
2018
Q2 		$936K Buy
+18,542
New +$966K 0.14% 276

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Teza Capital Management's EBS Position: Q3 2018 in Review

Teza Capital Management sold out of Emergent Biosolutions (EBS) in Q3 2018, closing a stake of 18,542 shares — an estimated $936K sold.

Teza Capital Management first reported a position in EBS in Q2 2018 and held it in 1 quarter. The position peaked at $936K in Q2 2018. 275 funds tracked by Wall St. Rank hold EBS as of Q3 2018.

  • Teza Capital Management reported no remaining Emergent Biosolutions position as of Q3 2018 after selling out during the quarter.
  • Teza Capital Management sold 18,542 Emergent Biosolutions shares in Q3 2018, an estimated $936K.
  • Teza Capital Management first reported a position in Emergent Biosolutions in Q2 2018 and held it in 1 quarter.
  • Teza Capital Management's Emergent Biosolutions position peaked at $936K in Q2 2018.
  • 275 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2018.

Based on Teza Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.